Reducing health disparities in chronic diseases in the Deep South
Deep South Center to Reduce Disparities in Chronic Diseases
This study is working to help people in Alabama, Mississippi, and Louisiana, especially Black Americans and those with low incomes, by creating personalized health programs to tackle obesity, diabetes, and high blood pressure in a way that fits their unique needs and cultures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10884907 on NIH RePORTER |
What this research studies
This research aims to address the high rates of obesity, diabetes, and hypertension in the Deep South, particularly among Black Americans and low-income populations. By employing a precision public health approach, the project focuses on delivering tailored interventions that consider cultural and individual factors to improve prevention, treatment, and management of cardiometabolic diseases. The initiative involves collaboration among multiple institutions to create a comprehensive strategy that promotes health equity across Alabama, Mississippi, and Louisiana.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black Americans and low-income individuals living in Alabama, Mississippi, and Louisiana who are affected by obesity, diabetes, or hypertension.
Not a fit: Patients outside the Deep South region or those not affected by cardiometabolic diseases may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve health outcomes and life expectancy for individuals suffering from chronic diseases in the Deep South.
How similar studies have performed: Previous research has shown success in addressing health disparities through targeted public health interventions, indicating that this approach has potential for positive outcomes.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cherrington, Andrea L — University of Alabama at Birmingham
- Study coordinator: Cherrington, Andrea L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.